Related Experiment Video
Updated: Jul 18, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[Hepatitis C in Chile: burden of the disease]
Alejandro Soza1, Marcelo López-Lastra
1Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Chile. asoza@med.puc.cl
Insights
Hepatitis C virus (HCV) infection causes significant liver disease and mortality globally. In Chile, HCV contributes substantially to cirrhosis deaths and is the leading cause of liver transplants in adults.
Area of Science:
- Hepatology
- Virology
- Epidemiology
Context:
- Hepatitis C virus-associated chronic hepatitis represents a major global health burden.
- Chile faces high mortality rates from cirrhosis, necessitating a closer look at contributing factors.
- Understanding the disease's prevalence and impact in Chile is crucial for public health strategies.
Purpose:
- To analyze clinical and epidemiological data on chronic hepatitis C in Chile.
- To compare Chilean data with regional (Latin America) and global trends.
- To assess the contribution of chronic hepatitis C to liver disease mortality and morbidity in Chile.
Summary:
- Chronic hepatitis C seroprevalence in Chile is 1.15% (ELISA III) and 0.85% (RIBA).
- Chile exhibits high overall cirrhosis mortality, with strong indirect evidence linking it to chronic hepatitis C.
- Hepatitis C is the primary indication for adult liver transplantation in Chile.
Impact:
- Highlights chronic hepatitis C as a significant public health issue in Chile.
- Provides a comparative analysis with Latin American and global hepatitis C data.
- Underscores the need for targeted interventions and improved management of hepatitis C in Chile.
Abstract:
Hepatitis C virus-associated chronic hepatitis is one of the most important causes of liver-related mortality and morbidity worldwide. This review analysis the available clinical and epidemiological information about this disease in Chile and compares it with data available from Latin America and other countries. Chronic hepatitis C seroprevalence in the general Chilean population is 1.15% by ELISA III and 0.85% by recombinant immunoblot assay (RIBA). Mortality due to cirrhosis (all causes) in Chile is one of the highest in the world. We show indirect evidence that chronic hepatitis C may account for a significant proportion of these deaths. The disease is the most common cause for liver transplantation in adults. Based on the available information, we conclude that chronic hepatitis C is an important cause of disease and mortality in Chile.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
American Trypanosomiasis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cholera
